• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024

September 20, 2024  

ECTRIMS 2024 HIGHLIGHTS – THURSDAY, SEPTEMBER 19, 2024

September 19, 2024  

ECTRIMS 2024 HIGHLIGHTS – WEDNESDAY, SEPTEMBER 18, 2024

September 18, 2024  

Does MS burn out?

August 20, 2024  

Utility of biomarkers in progressive MS

August 1, 2024  

Protein biomarker panel useful for MS diagnosis, prognosis

July 23, 2024  

REPORT FROM EAN 2024 – THURSDAY, JULY 4, 2024

July 4, 2024  

REPORT FROM EAN 2024 – WEDNESDAY, JULY 3, 2024

July 3, 2024  

REPORT FROM EAN 2024 – TUESDAY, JULY 2, 2024

July 2, 2024  

Inertia and uncertainty: is MS treatment truly optimized?

June 25, 2024  
Previous
4
5
6
7
8
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions